Rhumbline Advisers »

Freeline Therapeutics Holdings shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Freeline Therapeutics Holdings shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Freeline Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Freeline Therapeutics Holdings held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Freeline Therapeutics Holdings by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $984 155 6.35
2023-09-30 $487 115 4.23